More Post from the Author
- Sidus Space Announces Closing of Public Offering
- Kaltra Launches Next-Gen MCHEdesign With Full Integration Into MCHEselect -- Instant Simulation & Seamless Microchannel Coil Workflow
- HCLSoftware erwirbt Jaspersoft von der Cloud Software Group
- MindHYVE.ai and KPSIAJ Sign Strategic MOU to Advance AI-Driven Innovation in Education and Healthcare Across Karachi
- Samsung to Host Series of Tech Forums at CES 2026
Alvogen Issues Voluntary Nationwide Recall for One Lot of Fentanyl Transdermal System 25 mcg/h Due to a Defective Delivery System
Published on Mon 3 Feb 2025 2:31:05 UTC
Company Contact Information
Consumers:
866-770-3024
[emailprotected]
Press:
[emailprotected]
MORRISTOWN, N.J., Jan. 31, 2025 /PRNewswire/ -- Alvogen, Inc. is voluntarily recalling one lot of Fentanyl Transdermal System 25 mcg/h transdermal patches to the consumer level. The reason for the recall is that there is a potential that patches could be multi-stacked, adhered one on top of the other, in a single product pouch. This transdermal system is manufactured by Kindeva Drug Delivery L.P., Northridge, CA and is distributed by Alvogen, Inc. as a private label distributor.
More Post from the Author
- Sidus Space Announces Closing of Public Offering
- Kaltra Launches Next-Gen MCHEdesign With Full Integration Into MCHEselect -- Instant Simulation & Seamless Microchannel Coil Workflow
- HCLSoftware erwirbt Jaspersoft von der Cloud Software Group
- MindHYVE.ai and KPSIAJ Sign Strategic MOU to Advance AI-Driven Innovation in Education and Healthcare Across Karachi
- Samsung to Host Series of Tech Forums at CES 2026